Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-28

FDA Approved: GABAPENTIN — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved an original application for a generic gabapentin product from Granules Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)